Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Acute Myelogenous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00098033
What this trial is testing

Investigation of Clofarabine in Acute Leukemias

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia
University of Texas 64
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05319249
What this trial is testing

Natural Killer Cell Immunotherapy in Combination With PARP-inhibition in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
German Cancer Research Center 54
Early research (Phase 1)Study completedNCT06326697
What this trial is testing

Bioequivalence of Azacitidine 300 mg Film-Coated Tablets in Adult Patients With Acute Myeloid Leukaemia (AML)

Who this might be right for
Acute Myeloid Leukaemia
Hikma Pharmaceuticals LLC 32
Testing effectiveness (Phase 2)Ended earlyNCT00666497
What this trial is testing

Phase 2 Study of Azacitidine (Vidaza) vs MGCD0103 vs Combination in Elderly Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
Mirati Therapeutics Inc. 6
Testing effectiveness (Phase 2)Looking for participantsNCT03471260
What this trial is testing

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaHematopoietic and Lymphoid System NeoplasmMyelodysplastic Syndrome+3 more
M.D. Anderson Cancer Center 96
Testing effectiveness (Phase 2)WithdrawnNCT02204020
What this trial is testing

Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
University of Pittsburgh
Testing effectiveness (Phase 2)Looking for participantsNCT07028086
What this trial is testing

VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma

Who this might be right for
Acute Myeloid LeukemiaMyeloid Sarcoma
Ruijin Hospital 48
Early research (Phase 1)Looking for participantsNCT05748197
What this trial is testing

ADCLEC.syn1 in People With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center 40
Not applicableNot Yet RecruitingNCT07521124
What this trial is testing

ABC Maintenance Therapy for AML

Who this might be right for
Acute Myeloid Leukemia (AML) in Remission
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 104
Large-scale testing (Phase 3)Looking for participantsNCT06802718
What this trial is testing

Interferon-alpha As Maintenance Therapy for Favorable-risk Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Peking University People's Hospital 96
Early research (Phase 1)Study completedNCT01130662
What this trial is testing

Combination of Decitabine and Midostaurin in Patients Older Than 60 With Newly Diagnosed or Relapsed Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
University of Kansas 16
Testing effectiveness (Phase 2)Study completedNCT01550224
What this trial is testing

Temozolomide Plus Vorinostat in Relapse/Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia With 11q23-abnormality in Relapse
Steven E. Coutre 23
Testing effectiveness (Phase 2)Study completedNCT01572662
What this trial is testing

Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning

Who this might be right for
LeukemiaAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+7 more
M.D. Anderson Cancer Center 201
Testing effectiveness (Phase 2)Study completedNCT00040846
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+97 more
Fred Hutchinson Cancer Center 60
Large-scale testing (Phase 3)Study completedNCT05188326
What this trial is testing

Efficacy of 5-Aza for Post-Remission Therapy of Acute Myeloid Leukemia (AML) in Elderly Patients

Who this might be right for
Acute Myeloid Leukemia
Associazione Qol-one 54
Not applicableUnknownNCT04450784
What this trial is testing

ObServatory Children Acute RElated Therapy Leukemia

Who this might be right for
Leukemia, Myeloid, Acute
University Hospital, Bordeaux 40
Early research (Phase 1)Study completedNCT04176393
What this trial is testing

A China Bridging Study of Ivosidenib in r/r AML Subjects With an IDH1 Mutation

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia
CStone Pharmaceuticals 30
Testing effectiveness (Phase 2)Study completedNCT00469014
What this trial is testing

Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeChronic Myeloid Leukemia
M.D. Anderson Cancer Center 72
Early research (Phase 1)Study completedNCT01527838
What this trial is testing

Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Hodgkin's DiseaseChronic Lymphocytic Leukemia (CLL)+2 more
Fate Therapeutics 10
Large-scale testing (Phase 3)Study completedNCT00006348
What this trial is testing

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Alliance for Clinical Trials in Oncology 100
Next Page